Bilateral functional worsening following voretigene neparvovec therapy
Eye (Lond)
.
2023 Sep;37(13):2828-2829.
doi: 10.1038/s41433-023-02411-4.
Epub 2023 Feb 17.
Authors
Emmanuel Rebelo Neves
1
,
Ana Luísa Carvalho
2
3
4
,
Teresa Mesquita
1
,
Catarina Paiva
1
,
Mário Alfaiate
1
,
João Figueira
1
2
5
,
Joaquim Murta
1
2
5
,
João Pedro Marques
6
7
8
Affiliations
1
Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
2
Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.
3
Medical Genetics Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
4
University Clinic of Medical Genetics, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
5
University Clinic of Ophthalmology, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
6
Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.
[email protected]
.
7
Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.
[email protected]
.
8
University Clinic of Ophthalmology, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
[email protected]
.
PMID:
36801965
PMCID:
PMC10482937
DOI:
10.1038/s41433-023-02411-4
No abstract available
MeSH terms
Genetic Therapy
Humans
Retinal Dystrophies* / therapy